LH · 10-Q · 2026Q3 · Full report
Capital Return Program
LABCORP HOLDINGS INC. · 2026-10-30 · Importance 52 · Surprise 42 · Matches filing data
On July 8, 2026, the board authorized an additional $1,000.0 million of common-stock repurchases, bringing remaining authorization to $1,378.6 million at September 30, with no expiration date. Common-stock repurchases were $226.8 million higher in the first nine months of 2026 than in the comparable 2025 period. Labcorp paid $178.1 million in common-stock dividends during the first nine months of 2026. On October 21, 2026, it declared a $0.72-per-share dividend, approximately $59.0 million in aggregate, payable December 11, 2026.
Key facts
- On July 8, 2026, Labcorp’s Board authorized an additional $1,000.0 million of share repurchases; at September 30, 2026, the outstanding authorization totaled up to $1,378.6 million and had no expiration date. source
- On October 21, 2026, Labcorp announced a $0.72 per-share cash dividend, approximately $59.0 million in aggregate, payable December 11, 2026, to shareholders of record November 24, 2026. source
- Labcorp paid $178.1 million in common stock dividends in the nine months ended September 30, 2026. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | committed | -3.1% | On July 8, 2026, Labcorp’s Board authorized an additional $1,000.0 million of share repurchases; at September 30, 2026, the outstanding… |
| cash | negative | committed | -0.3% | On October 21, 2026, Labcorp announced a $0.72 per-share cash dividend, approximately $59.0 million in aggregate, payable December 11,… |